MRL-871   Click here for help

GtoPdb Ligand ID: 10642

Synonyms: MRL871
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: MRL-871 is a negative allosteric modulator of the nuclear hormone receptor RORγt [1,3]. It binds to a site in the receptor's ligand binding domain that is distal to the canonical ortherosteric binding site.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 72.19
Molecular weight 444.05
XLogP 6.45
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)c1ccc(cc1)c1nn(c2c1cccc2)C(=O)c1c(Cl)cccc1C(F)(F)F
Isomeric SMILES OC(=O)c1ccc(cc1)c1nn(c2c1cccc2)C(=O)c1c(Cl)cccc1C(F)(F)F
InChI InChI=1S/C22H12ClF3N2O3/c23-16-6-3-5-15(22(24,25)26)18(16)20(29)28-17-7-2-1-4-14(17)19(27-28)12-8-10-13(11-9-12)21(30)31/h1-11H,(H,30,31)
InChI Key DANLZOIRUUHIIX-UHFFFAOYSA-N
References
1. Azevedo RCRG, Barr KJ, Beresis RT, Cals J, Duan X, Karstens WFJ, van der Stelt M, Zhang D, Zhang H. (2012)
Rorgammat inhibitors.
Patent number: WO2012106995A1. Assignee: Merck Sharp & Dohme, Organon. Priority date: 11/02/2011. Publication date: 16/08/2012.
2. Fauber BP, Gobbi A, Robarge K, Zhou A, Barnard A, Cao J, Deng Y, Eidenschenk C, Everett C, Ganguli A et al.. (2015)
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists.
Bioorg Med Chem Lett, 25 (15): 2907-12. [PMID:26048793]
3. Scheepstra M, Leysen S, van Almen GC, Miller JR, Piesvaux J, Kutilek V, van Eenennaam H, Zhang H, Barr K, Nagpal S et al.. (2015)
Identification of an allosteric binding site for RORγt inhibition.
Nat Commun, 6: 8833. [PMID:26640126]